Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
Jun 14, 2018	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-18-193093.pdf 0001193125-18-193093.rtf 0001193125-18-193093.xls
Jun 14, 2018	UPLOAD	UPLOAD	View HTML 0000000000-18-018269.pdf
Jun 14, 2018	CORRESP	CORRESP	View HTML 0001193125-18-193101.pdf 0001193125-18-193101.rtf 0001193125-18-193101.xls
Jun 11, 2018	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-18-188635.pdf 0001193125-18-188635.rtf 0001193125-18-188635.xls
Jun 05, 2018	UPLOAD	UPLOAD	View HTML 0000000000-18-017206.pdf
Jun 01, 2018	CORRESP	CORRESP	View HTML 0001193125-18-181861.pdf 0001193125-18-181861.rtf 0001193125-18-181861.xls
May 30, 2018	UPLOAD	UPLOAD	View HTML 0000000000-18-016574.pdf
May 30, 2018	CORRESP	CORRESP	View HTML 0001193125-18-178736.pdf 0001193125-18-178736.rtf 0001193125-18-178736.xls
May 24, 2018	Registration statement for face-amount certificate companies	S-1	View HTML 0001193125-18-173711.pdf 0001193125-18-173711.rtf 0001193125-18-173711.xls
May 24, 2018	CORRESP	CORRESP	View HTML 0001193125-18-173720.pdf 0001193125-18-173720.rtf 0001193125-18-173720.xls

Data provided by Kaleidoscope.